Chemoinformaics analysis of METHYL 4-HYDROXYCINNAMATE
| Molecular Weight | 178.187 | nRot | 2 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 8 |
| Exact Molecular Weight | 178.063 | nRing | 1 |
| Solubility: LogS | -1.77 | nHRing | 0 |
| Solubility: LogP | 2.325 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 25.7739 |
| nHD | 1 | BPOL | 12.6361 |
| QED | 0.552 |
| Synth | 1.831 |
| Natural Product Likeliness | 0.87 |
| NR-PPAR-gamma | 0.048 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.029 |
| HIA | 0.009 |
| CACO-2 | -4.512 |
| MDCK | 0.0000217 |
| BBB | 0.842 |
| PPB | 0.796232 |
| VDSS | 0.568 |
| FU | 0.148302 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.65 |
| CYP2c19-inh | 0.781 |
| CYP2c19-sub | 0.33 |
| CYP2c9-inh | 0.422 |
| CYP2c9-sub | 0.924 |
| CYP2d6-inh | 0.055 |
| CYP2d6-sub | 0.822 |
| CYP3a4-inh | 0.114 |
| CYP3a4-sub | 0.308 |
| CL | 12.352 |
| T12 | 0.916 |
| hERG | 0.052 |
| Ames | 0.18 |
| ROA | 0.75 |
| SkinSen | 0.938 |
| Carcinogencity | 0.474 |
| EI | 0.477 |
| Respiratory | 0.514 |
| NR-Aromatase | 0.064 |
| Antiviral | No |
| Prediction | 0.874512 |